Evidence map›Paper›PMID 39460878›Full record

ArticleEJNMMI radiopharmacy and chemistry2024

Optimized method for fluorine-18 radiolabeling of Affibody molecules using RESCA.

Francesco Lechi, Jonas Eriksson, Luke R Odell, Olivia Wegrzyniak, John Löfblom, Fredrik Y Frejd, Bo Zhang, Olof Eriksson

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Aluminum-[EJNMMI radiopharmacy and chemistry · 2025
    Article
  3. Pharmaceutics · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francesco LechiDepartment of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Jonas ErikssonDepartment of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Luke R OdellDepartment of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Olivia WegrzyniakDepartment of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
John LöfblomDivision of Protein Engineering, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden.
Fredrik Y FrejdDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Bo ZhangDepartment of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Olof ErikssonDepartment of Medicinal Chemistry, Science for Life Laboratory, Uppsala University, Uppsala, Sweden. olof.eriksson@ilk.uu.se.ORCID http://orcid.org/0000-0002-2515-8790

Funding

Vetenskapsrådet 2020-02312
6 · The paper itself

Abstract

backgroundIn recent years, the interest in Al[

resultsThe Al[

conclusionsWe present a general and optimized method for Al[

Indexed as

Affibody moleculeAluminium fluoridePeptidePET imagingRadiochemistryRESCA

Identifiers

PMID39460878
PMCPMC11512968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.